Syneos Health

About Syneos Health

Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization.

Explore similar firms in the Biotechnology

Email Format

{first_name}.{last_name}@syneoshealth.com — 100.0%

sarah.smith@syneoshealth.com

Key Employees

Contact details of 9 Syneos Health executives

Ian Dorrian

President Communications Europe
  • Work email

    i*********n@syneoshealth.com

Deanne Melloy

Chief Commercial Officer

Aaron Davis

Senior Managing Director

Candace Kendle

Founder

Anthony Celeste

Senior Vice President

Hans Joerg Moebius

Senior Vice President

Pierre Geoffroy

Vice President

Dan Hartnett

CFO

mary vila

Vice President, Human Resources

Other Employees

Contact details of 11 Syneos Health other employees

Sean Wallace

Clinical Technician
  • Work email

    s**********e@syneoshealth.com

Elgin C Duckery

District Sales Manager
  • Work email

    e***********y@syneoshealth.com

Aparna Sree

Talent Acquisition Spec II
  • Work email

    a******p@syneoshealth.com

Agnieszka Mazek

International Corporate Recruiter II
  • Work email

    a*************k@syneoshealth.com

Anita Burroughs

Job not specified
  • Work email

    a*************s@syneoshealth.com

Susanna Giorgi

Job not specified
  • Work email

    s************i@syneoshealth.com

Tanvi Gangal

Global Trial Manager (supporting Bristol Myers Squibb)

Verna Wilson

Payroll Reporting Manager

Rob Wotring

Sr. Clinical Trial Manager

Jennifer Harris

VP, Immuno-Oncology Clinical Development

Julianna Thrasher

Diabetes Sales Specialist for Eli Lilly

General Emails

General company emails, e.g. customer support lines

    jobs@syneoshealth.com

    Career Opportunities

    abcdefghij@syneoshealth.com

    Unclassified inbox

    toby.marshall@syneoshealth.com

    Unclassified inbox

    corporatehumanresources@syneoshealth.com

    Unclassified inbox

    info@syneoshealth.com

    General Inquiries

    xxxx@syneoshealth.com

    Unclassified inbox

Similar Companies like Syneos Health

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Legal Name: AbbVie Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices Hospitals & Clinics

Legal Name: Medtronic, plc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Legal Name: Pfizer Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

Company Info

Last updated: 14/07/2025

+1 919 876 9300

Morrisville, North Carolina, United States

Syneos Health General Information

Specialization: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Legal Name: Syneos Health, Inc.
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Secondary
Founded Date: 1985
Company Type: For Profit
Stock Symbol: NASDAQ:SYNH
Operating Status: Active
Last Funding Type: Post-IPO Secondary
Phone Number: +1 919 876 9300
Last Investment Activity: Jan 12, 2024
Investments Activity: Jan 12, 2024 Jan 5, 2024 Dec 29, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.